European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 148, Issue 2 , Pages 186-190 , February 2010

Eligibility and willingness of first-year students entering university to participate in a HPV vaccination catch-up program

  • Françoise Mehu-Parant

      Affiliations

    • Inter-university Service of Preventive Medicine and Promotion of Health (SIMPPS), University Paul Sabatier, F-31062 Toulouse, France
    • ,
  • Roman Rouzier

      Affiliations

    • AP-HP, Hôpital Tenon, Department of Gynecology, F-75020 Paris, France
    • ,
  • Jean-Marc Soulat

      Affiliations

    • Inter-university Service of Preventive Medicine and Promotion of Health (SIMPPS), University Paul Sabatier, F-31062 Toulouse, France
    • INSERM Unity 558, F-31062 Toulouse, France
    • CHU de Toulouse, Department of Occupational and Environmental Medicine, F-31059 Toulouse, France
    • ,
  • Olivier Parant

      Affiliations

    • Hôpital Paule de Viguier- CHU de Toulouse, Department of Obstetrics and Gynecology, F-31059 Toulouse, France
    • Corresponding Author InformationCorresponding author at: Hôpital Paule de Viguier - Department of Obstetrics and Gynecology, 330 avenue de Grande-Bretagne - TSA 70034, F-31059 Toulouse Cedex 9, France. Tel.: +33 567771109; fax: +33 567771123.

Received 25 May 2009 ,Revised 19 August 2009 ,Accepted 19 October 2009.

References 

  1. Koulova A, Tsui J, Irwin K, Van Damme P, Biellik R, Aguado MT. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006–January 2008. Vaccine. 2008;26:6529–6541
  2. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157:218–226
  3. Gerend MA, Magloire ZF. Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health. 2008;42:237–242
  4. Boehner CW, Howe SR, Bernstein DI, Rosenthal SL. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis. 2003;30:774–778
  5. Jones M, Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health. 2008;57:23–32
  6. Ascherio A, Zhang SM, Hernàn MA, Olek MJ, Coplan PM, Brodovicz K, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med. 2001;344:327–332
  7. Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med. 2001;344:319–326
  8. European Cervical Cancer Association (ECCA). HPV vaccination across Europe (http://www.ecca.info).
  9. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008;359:821–832
  10. Winer RL, Feng Q, Hughes JP, O’Reilly S, Kiviat NB, Koutsky LA. Risk of female human papillomavirus acquisition associated with first male sexpartner. J Infect Dis. 2008;197:279–282
  11. Dempsey AF. Human papillomavirus: the usefulness of risk factors in determining who should get vaccinated. Rev Obstet Gynecol. 2008;1:122–128
  12. Ault KA. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol. 2006;(Suppl.):40470

PII: S0301-2115(09)00640-X

doi: 10.1016/j.ejogrb.2009.10.024

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 148, Issue 2 , Pages 186-190 , February 2010

Article Tools

* Image Usage & Resolution